You are here

Enhanced Therapeutic Effects with CD146-positive MSCs

A study led by Diego Correa (University of Miami, Florida, USA) recently described a CD146-positive subpopulation of mesenchymal stem cells (MSCs) that may provide for the therapeutic effect observed following treatments with “bulk” unsorted MSCs. Bowles et al. hope that this exciting finding will allow for the optimization of therapeutic cell selection for clinical application and a deeper understanding of the mechanisms of action regarding cell therapy. For all the fascinating details, see STEM CELLS now!